Hyunseok Kang
Hyunseok Kang
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Antitumor activity of pembrolizumab in biomarker-unselected patients with recurrent and/or metastatic head and neck squamous cell carcinoma: results from the phase Ib KEYNOTE …
LQM Chow, R Haddad, S Gupta, A Mahipal, R Mehra, M Tahara, R Berger, ...
Journal of Clinical Oncology 34 (32), 3838, 2016
5402016
Evolution of neoantigen landscape during immune checkpoint blockade in non–small cell lung cancer
V Anagnostou, KN Smith, PM Forde, N Niknafs, R Bhattacharya, J White, ...
Cancer discovery 7 (3), 264-276, 2017
4442017
Pembrolizumab for platinum-and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study
J Bauml, TY Seiwert, DG Pfister, F Worden, SV Liu, J Gilbert, NF Saba, ...
Journal of Clinical Oncology 35 (14), 1542, 2017
3692017
Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas
Y Wang, S Springer, CL Mulvey, N Silliman, J Schaefer, M Sausen, ...
Science translational medicine 7 (293), 293ra104-293ra104, 2015
2872015
Emerging biomarkers in head and neck cancer in the era of genomics
H Kang, A Kiess, C Chung
Nature Reviews Clinical Oncology, 2014
2302014
Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012
R Mehra, TY Seiwert, S Gupta, J Weiss, I Gluck, JP Eder, B Burtness, ...
British journal of cancer 119 (2), 153-159, 2018
1502018
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
CH Chung, VB Guthrie, DL Masica, C Tokheim, H Kang, J Richmon, ...
Annals of oncology 26 (6), 1216-1223, 2015
1372015
Head and neck PET/CT: therapy response interpretation criteria (Hopkins criteria)—interreader reliability, accuracy, and survival outcomes
C Marcus, A Ciarallo, AK Tahari, E Mena, W Koch, RL Wahl, AP Kiess, ...
Journal of Nuclear Medicine 55 (9), 1411-1416, 2014
1152014
Differences in the prevalence of human papillomavirus (HPV) in head and neck squamous cell cancers by sex, race, anatomic tumor site, and HPV detection method
G D’Souza, WH Westra, SJ Wang, A Van Zante, A Wentz, N Kluz, E Rettig, ...
JAMA oncology 3 (2), 169-177, 2017
812017
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers
LJ Wirth, E Sherman, B Robinson, B Solomon, H Kang, J Lorch, F Worden, ...
New England Journal of Medicine 383 (9), 825-835, 2020
662020
Whole-exome sequencing of salivary gland mucoepidermoid carcinoma
H Kang, M Tan, JA Bishop, S Jones, M Sausen, PK Ha, N Agrawal
Clinical Cancer Research 23 (1), 283-288, 2017
482017
Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity
L Rooper, K Theodoros, Y Ning, J Bishop, S Gordon, H Kang
American Journal of Surgical Pathology, 2018
472018
Evaluation of proposed staging systems for human papillomavirus‐related oropharyngeal squamous cell carcinoma
IJ Malm, CJ Fan, LX Yin, DX Li, WM Koch, CG Gourin, KT Pitman, ...
Cancer 123 (10), 1768-1777, 2017
452017
High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer …
R Guerrero-Preston, JR White, F Godoy-Vitorino, A Rodríguez-Hilario, ...
Oncotarget 8 (67), 110931, 2017
392017
Salivary duct carcinoma: an aggressive salivary gland malignancy with opportunities for targeted therapy
NC Schmitt, H Kang, A Sharma
Oral oncology 74, 40-48, 2017
392017
Genomic determinants of response to pembrolizumab in head and neck squamous cell carcinoma (HNSCC).
RI Haddad, TY Seiwert, LQM Chow, S Gupta, J Weiss, I Gluck, JP Eder, ...
Journal of Clinical Oncology 35 (15_suppl), 6009-6009, 2017
392017
FDG PET/CT in the management of nasopharyngeal carcinoma
A Mohandas, C Marcus, H Kang, MT Truong, RM Subramaniam
American Journal of Roentgenology 203 (2), W146-W157, 2014
392014
SMAD4 loss is associated with cetuximab resistance and induction of MAPK/JNK activation in head and neck cancer cells
H Ozawa, RS Ranaweera, E Izumchenko, E Makarev, A Zhavoronkov, ...
Clinical Cancer Research 23 (17), 5162-5175, 2017
382017
Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board
WB Dalton, PM Forde, H Kang, RM Connolly, V Stearns, CD Gocke, ...
JCO precision oncology 1, 1-19, 2017
382017
Class I HDACs Are Mediators of Smoke Carcinogen–Induced Stabilization of DNMT1 and Serve as Promising Targets for Chemoprevention of Lung Cancer
SA Brodie, G Li, A El-Kommos, H Kang, SS Ramalingam, M Behera, ...
Cancer prevention research 7 (3), 351-361, 2014
372014
The system can't perform the operation now. Try again later.
Articles 1–20